RPG Life Sciences Recommends Final Dividend of Rs. 24 Per Share for FY 2025-26
RPG Life Sciences Limited has announced plans regarding its dividend payment for the financial year ended March 31, 2026, following a Board meeting held on April 29, 2026. The company recommended a final dividend of Rs. 24 per equity share, which translates to 300% based on the face value of the stock.The suggested dividend is slated for shareholder approval at the Nineteenth Annual General Meeting (AGM), which is scheduled to be held on Thursday, July 23, 2026.
To determine entitlement to receive this final dividend, RPG Life Sciences fixed Thursday, July 9, 2026, as the Record Date.
The following details outline the security type, record date, and purpose associated with the payment:
| Security | Record Date | Dividend Purpose |
|---|---|---|
| Equity Shares (NSE: RPGLIFE / BSE: 532983) | Thursday, July 9, 2026 | Payment of final dividend of Rs. 24/- (300%) per Equity share of Rs. 8/- each for FY ended March 31, 2026, subject to AGM approval on July 23, 2026. |
The company confirmed that if the dividend is approved by the shareholders at the ensuing AGM, payment will be made within 30 days. This payment applies to members whose names appear in the Register of Members or the Register of Beneficial Owners maintained by the Depositories as on the Record Date.
RPGLIFE Stock Price Movement
Today, shares of RPG Life Sciences Limited gained 2.53% to settle at ₹2334.6 after closing the trading day in positive territory. The stock traded on a volume of 6,084 shares, staying within its intraday range of ₹2277 to ₹2350.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.